Rituximab News and Research

RSS
Rituximab is approved by the Food and Drug Administration (FDA) to be used alone or with other drugs to treat certain types of B-cell non-Hodgkin lymphoma. It is also approved to be used with methotrexate to treat rheumatoid arthritis. Rituximab is also being studied in the treatment of other types of cancer and other conditions.
Key discovery could prevent treatment failure in people with severe hemophilia A

Key discovery could prevent treatment failure in people with severe hemophilia A

New analysis technique could pave way for major breakthroughs in immunotherapy

New analysis technique could pave way for major breakthroughs in immunotherapy

New radioimmunotherapy effectively reverses resistance to lymphoma therapy

New radioimmunotherapy effectively reverses resistance to lymphoma therapy